← Browse by Condition
Medical Condition

hot flashes

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for hot flashes sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — hot flashes Clinical Trials

How many clinical trials are currently recruiting for hot flashes?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for hot flashes, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for hot flashes?
hot flashes research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a hot flashes clinical trial?
Eligibility criteria for hot flashes trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Top Sponsors
University of Virginia 1 trial
Astellas Pharma Europe Ltd. 1 trial
Bonafide Health 1 trial
University of Arkansas 1 trial
Shehzad Basaria, M.D. 1 trial

Recruiting Clinical Trials

NCT07535541
Recruiting
A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
Enrollment
18 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT07602530
Recruiting
A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical Practice
Enrollment
238 pts
Location
Canada
Sponsor
Astellas Pharma Europe Ltd.
View Trial →
NCT07238478
Recruiting
JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
Enrollment
250 pts
Location
United States
Sponsor
Bonafide Health
View Trial →
NCT01530373 Phase 2
Recruiting
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
Enrollment
110 pts
Location
United States
Sponsor
University of Arkansas
View Trial →
NCT06957691 Phase 2
Recruiting
Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Enrollment
60 pts
Location
United States
Sponsor
Shehzad Basaria, M.D.
View Trial →
NCT06487130
Recruiting
Virtual perI-/Menopause Registry of AusTrALia
Enrollment
10,000 pts
Location
Australia
Sponsor
Bespoke Clinical Research
View Trial →

Related Conditions

prostate cancer (2) vasomotor symptoms (2) androgen deprivation therapy (2) joint discomfort (1) joint pain stiffness function (1) joint pain (1) hot flash (1) night sweats (1) breast cancer (1) prostate cancer adenocarcinoma (1) prostate cancer metastatic disease (1) prostate cancer recurrent (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology